These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 32599663)

  • 1. Clinical prevalence and outcome of cardiovascular events in the first 100 days postallogeneic hematopoietic stem cell transplant.
    Alblooshi R; Kanfar S; Lord B; Atenafu EG; Michelis FV; Pasic I; Gerbitz A; Al-Shaibani Z; Viswabandya A; Kim DDH; Lam W; Law A; Mattsson J; Kumar R; Lipton JH
    Eur J Haematol; 2021 Jan; 106(1):32-39. PubMed ID: 32599663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular Risk Stratification of Patients Undergoing Hematopoietic Stem Cell Transplantation: The CARE-BMT Risk Score.
    Vasbinder A; Catalan T; Anderson E; Chu C; Kotzin M; Murphy D; Cheplowitz H; Diaz KM; Bitterman B; Pizzo I; Huang Y; Xie J; Hoeger CW; Kaakati R; Berlin HP; Shadid H; Perry D; Pan M; Takiar R; Padalia K; Mills J; Meloche C; Bardwell A; Rochlen M; Blakely P; Leja M; Banerjee M; Riwes M; Magenau J; Anand S; Ghosh M; Pawarode A; Yanik G; Nathan S; Maciejewski J; Okwuosa T; Hayek SS
    J Am Heart Assoc; 2024 Jan; 13(1):e033599. PubMed ID: 38158222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Premature cardiovascular disease after allogeneic hematopoietic stem-cell transplantation.
    Tichelli A; Bucher C; Rovó A; Stussi G; Stern M; Paulussen M; Halter J; Meyer-Monard S; Heim D; Tsakiris DA; Biedermann B; Passweg JR; Gratwohl A
    Blood; 2007 Nov; 110(9):3463-71. PubMed ID: 17664354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation.
    Tichelli A; Passweg J; Wójcik D; Rovó A; Harousseau JL; Masszi T; Zander A; Békássy A; Crawley C; Arat M; Sica S; Lutz P; Socié G;
    Haematologica; 2008 Aug; 93(8):1203-10. PubMed ID: 18556401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of atrial fibrillation prevalence and in-hospital cardiovascular outcomes between patients undergoing allogeneic versus autologous hematopoietic stem cell transplantation: insights from the national inpatient sample.
    Krishan S; Asad ZUA; Quiroga D; Ghazi SM; Quartermaine C; Braunstein Z; Kola-Kehinde O; Shaaban A; Habib A; Khan S; Cheng R; Brammer JE; Addison D
    Sci Rep; 2024 Jul; 14(1):16829. PubMed ID: 39039091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Etiologies and Impact of Readmission Rates in the First 180 Days After Hematopoietic Stem Cell Transplantation in Children, Adolescents, and Young Adults.
    Maher OM; Silva JG; Huh WW; Cuglievan B; DePombo A; Kebriaei P; Park M; Liu D; Tillman C; Tarek N; Cooper LJN; Tewari P
    J Pediatr Hematol Oncol; 2017 Nov; 39(8):609-613. PubMed ID: 28859043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low pre-transplant levels of mannose-binding lectin are associated with viral infections and mortality after haematopoietic allogeneic stem cell transplantation.
    Puente M; Fariñas-Alvarez C; Moreto A; Sánchez-Velasco P; Ocejo-Vinyals JG; Fariñas MC;
    BMC Immunol; 2019 Nov; 20(1):40. PubMed ID: 31706269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular Events After Hematopoietic Stem Cell Transplant: Incidence and Risk Factors.
    Vasbinder A; Hoeger CW; Catalan T; Anderson E; Chu C; Kotzin M; Xie J; Kaakati R; Berlin HP; Shadid H; Perry D; Pan M; Takiar R; Padalia K; Mills J; Meloche C; Bardwell A; Rochlen M; Blakely P; Leja M; Banerjee M; Riwes M; Magenau J; Anand S; Ghosh M; Pawarode A; Yanik G; Nathan S; Maciejewski J; Okwuosa T; Hayek SS
    JACC CardioOncol; 2023 Dec; 5(6):821-832. PubMed ID: 38205002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical analysis of acute renal failure after allogeneic hematopoietic stem cell transplantation].
    Zhou T; Cen XN; Qiu ZX; Ou JP; Wang WS; Xu WL; Li Y; Wang MJ; Wang LH; Tong YJ; Ren HY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Jun; 17(3):723-8. PubMed ID: 19549395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycemic variability is associated with poor outcomes in pediatric hematopoietic stem cell transplant patients.
    Sopfe J; Campbell K; Keating AK; Pyle L; Liu AK; Verneris MR; Giller RH; Forlenza GP
    Pediatr Blood Cancer; 2020 Nov; 67(11):e28626. PubMed ID: 33480469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and risk factors of probable and proven invasive fungal infection in adult patients receiving allogeneic hematopoietic stem cell transplantation.
    Liu YC; Chien SH; Fan NW; Hu MH; Gau JP; Liu CJ; Yu YB; Liu CY; Hsiao LT; Liu JH; Chiou TJ; Chen PM; Tzeng CH
    J Microbiol Immunol Infect; 2016 Aug; 49(4):567-74. PubMed ID: 25735797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-Transplantation Natural Killer Cell Count: A Predictor of Acute Graft-Versus-Host Disease and Survival Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation.
    Kim SY; Lee H; Han MS; Shim H; Eom HS; Park B; Kong SY
    Clin Lymphoma Myeloma Leuk; 2016 Sep; 16(9):527-535.e2. PubMed ID: 27375156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late cardiovascular complications after hematopoietic cell transplantation.
    Chow EJ; Wong K; Lee SJ; Cushing-Haugen KL; Flowers ME; Friedman DL; Leisenring WM; Martin PJ; Mueller BA; Baker KS
    Biol Blood Marrow Transplant; 2014 Jun; 20(6):794-800. PubMed ID: 24565992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Allogeneic Hematopoietic Stem Cell Transplant for Chronic Granulomatous Disease (CGD): a Report of the United States Immunodeficiency Network.
    Yonkof JR; Gupta A; Fu P; Garabedian E; Dalal J;
    J Clin Immunol; 2019 May; 39(4):448-458. PubMed ID: 31111420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WT1 Measurable Residual Disease Assay in Patients With Acute Myeloid Leukemia Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation: Optimal Time Points, Thresholds, and Candidates.
    Cho BS; Min GJ; Park SS; Shin SH; Yahng SA; Jeon YW; Yoon JH; Lee SE; Eom KS; Kim YJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Kim M; Kim Y; Kim HJ
    Biol Blood Marrow Transplant; 2019 Oct; 25(10):1925-1932. PubMed ID: 31173897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Negative Impact of Cytomegalovirus Reactivation on Survival in Adult Patients with Aplastic Anemia after an Allogeneic Hematopoietic Stem Cell Transplantation: A Report from Transplantation-Related Complication and Adult Aplastic Anemia Working Groups of the Japan Society for Hematopoietic Cell Transplantation.
    Takenaka K; Onishi Y; Mori T; Hirakawa T; Tada Y; Uchida N; Kobayashi T; Kanda Y; Ozawa Y; Ota S; Iida H; Fukushima K; Kimua T; Fukuda T; Atsuta Y; Matsuto K; Yamazaki H; Nakasone H
    Transplant Cell Ther; 2021 Jan; 27(1):82.e1-82.e8. PubMed ID: 33039517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurological Complications Involving the Central Nervous System After Allogeneic Hematopoietic Stem Cell Transplantation During a Period of Evolution in Transplant Modalities: A Cohort Analysis.
    Colombo AA; Marchioni E; Diamanti L; Di Matteo AM; Baldanti F; Furione M; Cazzola M; Ferretti VV; Pascutto C; Alessandrino EP
    Transplantation; 2017 Mar; 101(3):616-623. PubMed ID: 27222935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Second Solid Cancers After Hematopoietic Stem Cell Transplantation in European Patients.
    Tichelli A; Beohou E; Labopin M; Socié G; Rovó A; Badoglio M; van Biezen A; Bader P; Duarte RF; Basak G; Salooja N;
    JAMA Oncol; 2019 Feb; 5(2):229-235. PubMed ID: 30476975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical and economic impact of cytomegalovirus infection in recipients of hematopoietic stem cell transplantation.
    Webb BJ; Harrington R; Schwartz J; Kammerer J; Spalding J; Lee E; Dodds B; Kaufusi S; Goodman BE; Firth SD; Martin G; Sorensen J; Hoda D
    Transpl Infect Dis; 2018 Oct; 20(5):e12961. PubMed ID: 29975816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pretransplant serum ferritin level may be a predictive marker for outcomes in patients having undergone allogeneic hematopoietic stem cell transplantation.
    Sivgin S; Baldane S; Kaynar L; Kurnaz F; Pala C; Ozturk A; Cetin M; Unal A; Eser B
    Neoplasma; 2012; 59(2):183-90. PubMed ID: 22248276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.